Literature DB >> 1522360

Intravascular hemolysis and acute renal failure following intermittent rifampin therapy.

A Gupta1, V Sakhuja, K L Gupta, K S Chugh.   

Abstract

Renal failure is a rare complication associated with the use of rifampin. Intravascular hemolysis leading to acute renal failure following rifampin therapy is extremely rare. Two patients with leprosy who developed hemolysis and acute renal failure following rifampin are reported.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1522360

Source DB:  PubMed          Journal:  Int J Lepr Other Mycobact Dis        ISSN： 0148-916X


  3 in total

Review 1.  Comparative pharmacokinetics and pharmacodynamics of the rifamycin antibacterials.

Authors:  W J Burman; K Gallicano; C Peloquin
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

2.  Sulphatide-binding properties are shared by serum amyloid P component and a polyreactive germ-line IgM autoantibody, the TH3 idiotype.

Authors:  P R Wheeler; J G Raynes; G M O'Sullivan; D Duggan; K P McAdam
Journal:  Clin Exp Immunol       Date:  1998-05       Impact factor: 4.330

Review 3.  Hypersensitivity reaction with multi-organ failure following re-exposure to rifampicin: case report and review of the literature including WHO spontaneous safety reports.

Authors:  Lisa Brockhaus; Yasmin Schmid; Anna C Rast; Alexandra E Rätz Bravo; Kathrin Scherer Hofmeier; Anne B Leuppi-Taegtmeyer
Journal:  BMC Pharmacol Toxicol       Date:  2019-02-12       Impact factor: 2.483
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.